Common Contracts
4 similar Control Severance Agreement contracts by Ardelyx, Inc.
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTControl Severance Agreement • August 6th, 2020 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Justin Renz (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as June 8, 2020 (the “Effective Date”).
ARDELYX, INC. SECOND AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTControl Severance Agreement • May 8th, 2018 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Second Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into this 7th day of May 2018 by and between David P. Rosenbaum, Ph.D. (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as January 19, 2017 (the “Effective Date”). This Agreement amends and restates in its entirety that certain Amended and Restated Change in Control Severance Agreement by and between Executive and the Company effective as of June 6, 2014 (the “Prior Agreement”)
ARDELYX, INC. SECOND AMENDED AND RESTATED CHANGE IN CONTROL SEVERANCE AGREEMENTControl Severance Agreement • May 8th, 2018 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Second Amended and Restated Change in Control Severance Agreement (the “Agreement”) is made and entered into this 7th day of May 2018 by and between Elizabeth Grammer (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as January 16, 2018 (the “Effective Date”). This Agreement amends and restates in its entirety that certain Amended and Restated Change in Control Severance Agreement by and between Executive and the Company effective as of June 6, 2014 (the “Prior Agreement”)
ARDELYX, INC. CHANGE IN CONTROL SEVERANCE AGREEMENTControl Severance Agreement • February 17th, 2017 • Ardelyx, Inc. • Pharmaceutical preparations • California
This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Bryan Shaw (the “Executive”) and Ardelyx, Inc. (the “Company”), effective as of the 6th day of December 2016 (the “Effective Date”).
